Status:

RECRUITING

Effect of Limaprost in Combination With Transforaminal Epidural Steroid Injection

Lead Sponsor:

Seoul National University

Collaborating Sponsors:

SMG-SNU Boramae Medical Center

Conditions:

Lumbar Spinal Stenosis

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The purpose of this study was to compare the effects of limaprost(Opalmon® ) on walking ability, low back pain and leg pain after transforaminal epidural steroid injection (TFESI) was administered com...

Detailed Description

This study is a prospective, randomized, comparative clinical study that is assigned to a placebo group or a trial group before transforaminal epidural steroid injection (TFESI) is performed. The sub...

Eligibility Criteria

Inclusion

  • Patients aged 18 to 85 years
  • Patients with a new or known diagnosis of lumbar spinal stenosis on Magnetic Resonance Imaging (MRI)
  • Patients scheduled to undergo TFESI due to low back pain or leg pain

Exclusion

  • Refusal of a patient
  • Coagulopathy
  • Systemic infection or local infection at the needle injection site
  • Patients with lumbar instability
  • Neoplasms in the needle path
  • Allergy to amide-type local anesthetics
  • Decreased cognition to the extent that NRS is incomprehensible
  • Patients with peripheral vascular disease (including peripheral arterial disease)
  • Patients taking anticoagulant or antiplatelet drugs
  • Patients with severe cardiovascular disease or liver or kidney disease
  • Patinets with cerebral infarction
  • Patinets with a history of gastrointestinal bleeding
  • Patinets who have had lumbar spine surgery or are expected to receive it within 12 months
  • Patients who show positive in the straight leg elevation test
  • Patients who are allergic or sensitive to limaprost (Opalmon®) and placebo or their ingredients

Key Trial Info

Start Date :

November 10 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2025

Estimated Enrollment :

104 Patients enrolled

Trial Details

Trial ID

NCT04876612

Start Date

November 10 2021

End Date

August 31 2025

Last Update

May 29 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea